12 Aug Froedtert & The Medical College of Wisconsin elevated to full member of Gynecologic Oncology Group
Froedtert & The Medical College of Wisconsin have been elevated to full membership in the Gynecologic Oncology Group (GOG), a National Cancer Institute (NCI)-funded cooperative cancer research group. This promotion from provisional membership is due, in part, to a substantial increase in patients enrolled in studies and a very positive GOG audit of our facilities and programs, and allows the Froedtert & The Medical College program to more fully participate in GOG-sponsored clinical trials focused on gynecologic malignancies.
In addition to being elevated to full GOG membership, the Froedtert & The Medical College gynecologic oncology group was recently invited to become a provisional member of the GOG Phase I Working Group, which is responsible for performing phase I trials of new agents in gynecologic cancers. Combined, these allow us to offer patients the highest quality and most cutting-edge research treatment options available, as well as a range of studies that address the quality of life issues they face.
Gynecologic malignancies include cancer of the ovary, uterus, cervix, vagina and vulva. The Froedtert & The Medical College of Wisconsin gynecologic oncology group is comprised of three board certified gynecologic oncologists: Janet Rader, MD, Jack A. and Elaine D. Klieger Professor and Chair of Obstetrics and Gynecology, Denise Uyar, MD, Associate Professor of Obstetrics and Gynecology, and William Bradley, MD, Assistant Professor of Obstetrics and Gynecology. Dr. Bradley serves as the Principal Investigator for our GOG studies.
GOG is a national organization focused on promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies. The group is committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of results. Continuous evaluation of our processes is utilized in order to constantly improve the quality of patient care. There are approximately 50 full members nationwide, and more than 3,300 patients are registered each year to participate in GOG clinical trials.